News | EP Lab | October 18, 2017

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course

Training course helps interventional cardiologists learn to use high-tech tools to better perform complex procedures

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course

October 18, 2017 — Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at helping cardiologists perform a complex procedure that is quickly becoming the gold standard for treating patients with atrial fibrillation and other structural heart diseases.

The two companies are working with a network of highly respected physicians to offer the Baylis Education Hands-On Transseptal Course. This hands-on training program was launched in response to the growing need for minimally invasive procedures that require access to the left side of the heart. For example, a transseptal puncture through the septum is a standard procedure for accessing the left atrium.

"There has been a huge growth in left-side structural procedures, which all require very precise transseptal access, yet many interventional cardiologists and cardiac surgeons haven't had the opportunity to learn transseptal techniques," said instructor Brijeshwar Maini, M.D., interventional cardiologist and regional medical director of transcatheter therapies for Tenet Healthcare's Florida Region. "Our first course got very positive feedback from physicians. They recognize the importance in gaining experience with the best available tools to ensure the best possible outcomes for their patients."

Interventional cardiologists have previously used a sharp mechanical needle to access the left side of the heart, which has been demonstrated in comparative clinical studies to be more time-consuming and have a higher risk of complications, such as cardiac tamponade, relative to using a radiofrequency needle.i Procedural complications may result in longer hospital stays and higher per-patient costs. Published studies have found that the Baylis Radiofrequency NRG Transseptal Needle Transseptal RF solution, which uses a short and highly focused radiofrequency (RF) energy pulse, allows a puncture that is more predictable and has the potential to minimize complications.ii

The combination of growing medical need coupled with the availability of smaller and more sophisticated cardiac implants is making catheter-based procedures more common. The new educational course offered by Baylis and Siemens Healthineers provides interventional cardiologists and surgeons with the skills they need to use more high-tech tools that provide greater precision and less risk in accessing the left atrium. The tools in this course include Baylis' NRG Transseptal Needle and Siemens Healthineers Acuson SC2000 Prime ultrasound system.

Interventional cardiologists and cardiac surgeons are also increasingly relying on visualization tools to accurately guide catheters and implants within the beating heart. The transesophageal echo (TEE) and intracardiac echo (ICE) tools on the Acuson SC2000 Prime offer ultrasound images that help make complex transseptal structural heart procedures straightforward. Physicians attending the course are able to use tools such as real-time septal guidance for more precise septal crossing and better outcomes.

Baylis and Siemens Healthineers sponsored the first joint course this past spring in Atlanta. Based on positive feedback from participants, the companies partnered to offer the course in other U.S. cities.

For more information: www.siemens.com/healthineers, www.baylismedical.com

Watch the VIDEO "Transcatheter Structural Heart Procedure Navigation Technology Advances"

Watch the VIDEO "What is Required for Interventional Echo? A Discussion With Rebecca Hahn"

References

i. Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Sep 17;2(5): e000428.

Winkle RA, Mead RH, Engel G, Patrawala RA. The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm. 2011 Sep;8(9):1411-5

ii. Ibid

Related Content

Atrial Fibrillation Patients Diagnosed With Carotid Atery Disease Face Increased Risk of Dementia

Image courtesy of Intermountain Medical Center Heart Institute

News | Atrial Fibrillation | May 24, 2018
Atrial fibrillation patients who are diagnosed with carotid artery disease face higher risks for developing dementia,...
Botulinum Toxin (botox) Injection in CABG Patients Reduces AFib After Cardiac Surgery. #HRS2018

Figure 1: At the end of 36 months, the incidence of any atrial tachyarrhythmia was 23.3 percent in the botox group, as compared to 50 percent in the placebo group

News | Atrial Fibrillation | May 18, 2018
 
Atrial fibrillation ablation using the Abbott Ensite electro mapping system. CABANA Trial Confirms Ablation Equal To or Superior to Drug Therapy. #HRS2018

Atrial fibrillation ablation using the Abbott Ensite electro mapping system.

Feature | Atrial Fibrillation | May 17, 2018
May 16, 2018 – The first results of the randomized, multicenter, long-term, international...
Link Found Between Post-Traumatic Stress, Increased Risk of AFib. #HRS2018
News | Atrial Fibrillation | May 15, 2018
May 15, 2018 — A new study is the first to report a relationship between post-traumatic stress disorder (PTSD) and ne
Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk. #HRS2018
News | Atrial Fibrillation | May 15, 2018
May 15, 2018 — According to new research, smoking marijuana may not be associated with an increased risk of ventricul
First Results Reported from AVIATOR 2 Registry for AFib Patients Undergoing PCI.

Photo courtesy of the American Heart Association

News | Atrial Fibrillation | May 15, 2018
May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception a
New Combined Risk Score More Effectively Predicts Stroke Risk in AFib Patients

Image courtesy of Intermountain Medical Center Heart Institute

News | Atrial Fibrillation | May 11, 2018
A new study finds that integrating two separate clinical risk score models more accurately helps clinicians assess the...
Depression Linked to Increased Atrial Fibrillation Risk
News | Atrial Fibrillation | March 27, 2018
March 27, 2018 — Depression may increase the risk for...
Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation.

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation. The technology allows different energies to be used for each electrode to prevent damage to the esophagus or other underlying critical structures. 

Feature | Atrial Fibrillation | January 15, 2018 | Dave Fornell
The development of atrial fibrillation (AFib or AF) ablation technologies over the past 20 years has been a constant
Overlay Init